Atherosclerosis Risk in Communities (ARIC) - Full Text View

Atherosclerosis Risk in Communities (ARIC)

This study is ongoing, but not recruiting participants.

Sponsored by:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00005131

Purpose

To measure associations of established and suspected coronary heart disease risk factors with both atherosclerosis and new coronary heart disease events in representative cohorts from four diverse United States communities. To compare the communities with respect to risk factors, medical care, atherosclerosis, and coronary heart disease incidence. ARIC has two components in each community: study of representative cohorts of adult men and women, and community surveillance of morbidity and mortality.

Condition

Atherosclerosis
Coronary Disease
Coronary Heart Disease Risk Reduction
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Heart Failure, Congestive
Heart Failure

MedlinePlus related topics:

Diabetes Heart Diseases Heart Failure

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	July 1985
Estimated Study Completion Date:	January 2007

Show Detailed Description

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

No eligibility criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005131

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators


Investigator:	Christie Ballantyne	Baylor College of Medicine

Investigator:	Lloyd Chambless	University of North Carolina

Investigator:	Josef Coresh	Johns Hopkins University

Investigator:	Matthew Davis	University of Wisconsin, Madison

Investigator:	Aaron Folsom	University of Minnesota

Investigator:	Gerardo Heiss	University of North Carolina

Investigator:	Daniel Jones	University of Mississippi Medical Center

Investigator:	Kenneth Wu	Texas Health Science Center

More Information

Related Info This link exits the ClinicalTrials.gov site

Study ID Numbers:	1001
First Received:	May 25, 2000
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00005131
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Atherosclerosis

Arterial Occlusive Diseases

Heart Failure

Heart Diseases

Metabolic Diseases

Myocardial Ischemia

Diabetes Mellitus

Vascular Diseases

Endocrine System Diseases

Arteriosclerosis

Ischemia

Coronary Disease

Endocrinopathy

Metabolic disorder

Glucose Metabolism Disorders

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 05, 2008